208 related articles for article (PubMed ID: 21050433)
1. Enhanced angiogenic potency of monocytic endothelial progenitor cells in patients with systemic sclerosis.
Yamaguchi Y; Okazaki Y; Seta N; Satoh T; Takahashi K; Ikezawa Z; Kuwana M
Arthritis Res Ther; 2010; 12(6):R205. PubMed ID: 21050433
[TBL] [Abstract][Full Text] [Related]
2. [Roles of aberrant endothelial progenitor cells in pathogenesis of systemic sclerosis].
Kuwana M
Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(1):17-26. PubMed ID: 23445728
[TBL] [Abstract][Full Text] [Related]
3. Brief report: impaired in vivo neovascularization capacity of endothelial progenitor cells in patients with systemic sclerosis.
Kuwana M; Okazaki Y
Arthritis Rheumatol; 2014 May; 66(5):1300-5. PubMed ID: 24782187
[TBL] [Abstract][Full Text] [Related]
4. Altered Properties of Endothelial Cells and Mesenchymal Stem Cells Underlying the Development of Scleroderma-like Vasculopathy in KLF5
Nakamura K; Taniguchi T; Hirabayashi M; Yamashita T; Saigusa R; Miura S; Takahashi T; Toyama T; Ichimura Y; Yoshizaki A; Trojanowska M; Fujiu K; Nagai R; Sato S; Asano Y
Arthritis Rheumatol; 2020 Dec; 72(12):2136-2146. PubMed ID: 32627966
[TBL] [Abstract][Full Text] [Related]
5. Proangiogenic hematopoietic cells of monocytic origin: roles in vascular regeneration and pathogenic processes of systemic sclerosis.
Yamaguchi Y; Kuwana M
Histol Histopathol; 2013 Feb; 28(2):175-83. PubMed ID: 23275301
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow endothelial progenitors are defective in systemic sclerosis.
Del Papa N; Quirici N; Soligo D; Scavullo C; Cortiana M; Borsotti C; Maglione W; Comina DP; Vitali C; Fraticelli P; Gabrielli A; Cortelezzi A; Lambertenghi-Deliliers G
Arthritis Rheum; 2006 Aug; 54(8):2605-15. PubMed ID: 16868984
[TBL] [Abstract][Full Text] [Related]
7. Capillaroscopic pattern in systemic sclerosis - an association with dynamics of processes of angio- and vasculogenesis.
Lambova SN; Müller-Ladner U
Microvasc Res; 2010 Dec; 80(3):534-9. PubMed ID: 20654632
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis in systemic sclerosis: impaired expression of vascular endothelial growth factor receptor 1 in endothelial progenitor-derived cells under hypoxic conditions.
Avouac J; Wipff J; Goldman O; Ruiz B; Couraud PO; Chiocchia G; Kahan A; Boileau C; Uzan G; Allanore Y
Arthritis Rheum; 2008 Nov; 58(11):3550-61. PubMed ID: 18975312
[TBL] [Abstract][Full Text] [Related]
9. Circulating endothelial progenitor cells in systemic sclerosis: relation to impaired angiogenesis and cardiovascular manifestations.
Nevskaya T; Bykovskaia S; Lyssuk E; Shakhov I; Zaprjagaeva M; Mach E; Ananieva L; Guseva N; Nassonov E
Clin Exp Rheumatol; 2008; 26(3):421-9. PubMed ID: 18578963
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis.
Romano E; Chora I; Manetti M; Mazzotta C; Rosa I; Bellando-Randone S; Blagojevic J; Soares R; Avouac J; Allanore Y; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
Ann Rheum Dis; 2016 Aug; 75(8):1541-9. PubMed ID: 26359450
[TBL] [Abstract][Full Text] [Related]
11. Decreased numbers of endothelial progenitor cells in patients in the early stages of systemic sclerosis.
Andrigueti FV; Arismendi MI; Ebbing PC; Kayser C
Microvasc Res; 2015 Mar; 98():82-7. PubMed ID: 25596148
[TBL] [Abstract][Full Text] [Related]
12. Systemic Sclerosis Serum Significantly Impairs the Multi-Step Lymphangiogenic Process: in Vitro Evidence.
Manetti M; Romano E; Rosa I; Fioretto BS; Guiducci S; Bellando-Randone S; Pigatto E; Cozzi F; Ibba-Manneschi L; Matucci-Cerinic M
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817940
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of angiogenesis by platelets in systemic sclerosis patients.
Hirigoyen D; Burgos PI; Mezzano V; Duran J; Barrientos M; Saez CG; Panes O; Mezzano D; Iruretagoyena M
Arthritis Res Ther; 2015 Nov; 17():332. PubMed ID: 26584613
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis.
Manetti M; Guiducci S; Romano E; Avouac J; Rosa I; Ruiz B; Lepri G; Bellando-Randone S; Ibba-Manneschi L; Allanore Y; Matucci-Cerinic M
Arthritis Res Ther; 2013 Oct; 15(5):R165. PubMed ID: 24286167
[TBL] [Abstract][Full Text] [Related]
15. The Role of Endothelial Progenitors in the Repair of Vascular Damage in Systemic Sclerosis.
Del Papa N; Pignataro F
Front Immunol; 2018; 9():1383. PubMed ID: 29967618
[TBL] [Abstract][Full Text] [Related]
16. Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis.
Cipriani P; Guiducci S; Miniati I; Cinelli M; Urbani S; Marrelli A; Dolo V; Pavan A; Saccardi R; Tyndall A; Giacomelli R; Cerinic MM
Arthritis Rheum; 2007 Jun; 56(6):1994-2004. PubMed ID: 17530639
[TBL] [Abstract][Full Text] [Related]
17. Insights into the pathogenesis of systemic sclerosis based on the gene expression profile of progenitor-derived endothelial cells.
Avouac J; Cagnard N; Distler JH; Schoindre Y; Ruiz B; Couraud PO; Uzan G; Boileau C; Chiocchia G; Allanore Y
Arthritis Rheum; 2011 Nov; 63(11):3552-62. PubMed ID: 21769840
[TBL] [Abstract][Full Text] [Related]
18. Cellular players in angiogenesis during the course of systemic sclerosis.
Cipriani P; Marrelli A; Liakouli V; Di Benedetto P; Giacomelli R
Autoimmun Rev; 2011 Aug; 10(10):641-6. PubMed ID: 21549220
[TBL] [Abstract][Full Text] [Related]
19. Increased serum levels of fractalkine and mobilisation of CD34
Benyamine A; Magalon J; Cointe S; Lacroix R; Arnaud L; Bardin N; Rossi P; Francès Y; Bernard-Guervilly F; Kaplanski G; Harlé JR; Weiller PJ; Berbis P; Braunstein D; Jouve E; Lesavre N; Couranjou F; Dignat-George F; Sabatier F; Paul P; Granel B
Arthritis Res Ther; 2017 Mar; 19(1):60. PubMed ID: 28320472
[TBL] [Abstract][Full Text] [Related]
20. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2.
Oh HK; Ha JM; O E; Lee BH; Lee SK; Shim BS; Hong YK; Joe YA
Cancer Res; 2007 May; 67(10):4851-9. PubMed ID: 17510415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
